Comparison of Preference for NovoPen® 4 With Previous Insulin Pen Treatments After 12 Weeks in Adult Patients With Type 1 and Type 2 Diabetes: A Multicenter Observational Study

Abstract Background In separate randomized, crossover trials, patients with diabetes reported a preference for durable insulin pen NovoPen® 4 compared with NovoPen 3 and OptiClik®. Objective This large post-marketing observational study evaluated treatment satisfaction with NovoPen 4 versus previous...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2011-03, Vol.33 (3), p.346-357
Hauptverfasser:	Israël-Bultman, Harma, Hyllested-Winge, Jacob, MD, Kolaczynski, Marcin, MD, Steindorf, Jörg, MD, Garon, Jean, MD, FRCPc
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Clinical medicine Diabetes diabetes mellitus Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 2 - drug therapy Diabetes. Impaired glucose tolerance Drug Delivery Systems - instrumentation Drug Delivery Systems - methods Drug dosages Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Injections, Subcutaneous Insulin Insulin - administration & dosage Insulin - therapeutic use insulin pen Internal Medicine Male Medical Education Medical sciences Middle Aged NovoPen Patient Education as Topic Patient Preference Pharmacology. Drug treatments Product Surveillance, Postmarketing Self Administration - instrumentation Studies Surveys and Questionnaires
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!